This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980
Title: Kenneth A. Kerridge: Innovator in Pharmaceutical Chemistry
Introduction
Kenneth A. Kerridge is a notable inventor based in Syracuse, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with advantageous biological properties.
Latest Patents
Kerridge holds a patent for "Methoxyethoxymethyl esters of penicillins." This patent exemplifies the synthesis of β-Methoxyethoxymethyl esters of cephalosporins and penicillins, specifically hetacillin and heta-amoxicillin. These compounds have been found to exhibit beneficial biological properties, showcasing Kerridge's innovative approach to drug development.
Career Highlights
Kerridge is associated with Bristol-Myers Company, where he has contributed to various research initiatives. His work has focused on enhancing the efficacy of antibiotic compounds, which is crucial in the ongoing battle against bacterial infections.
Collaborations
Kerridge has collaborated with fellow researcher Julius A. Vida, working together to advance their understanding of pharmaceutical compounds and their applications.
Conclusion
Kenneth A. Kerridge's contributions to pharmaceutical chemistry, particularly through his patent on methoxyethoxymethyl esters, highlight his role as an innovator in the field. His work continues to influence the development of effective antibiotic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile